COSMOS Pharmaceutical CorporationJP:3349

Market cap
¥632,613m
P/E ratio
26.3
SummaryIncome statementBalance sheetCash flow
May 31,
2013		May 31,
2014		May 31,
2015		May 31,
2016		May 31,
2017		May 31,
2018		May 31,
2019		May 31,
2020		May 31,
2021		May 31,
2022		May 31,
2023
Net sales329,313371,825408,466447,273502,732557,999611,137684,403726,424755,414827,697
Cost of sales267,527301,268330,391360,420402,688447,681489,353549,419581,313603,966658,979
Gross profit (loss)
Selling, general and administrative expenses
Operating profit (loss)
Interest income
Commission income
Rental income from real estate
Gain on receipt of donated non-current assets
Other
Non-operating income
Interest expenses
Rental costs on real estate
Other
Non-operating expenses
Ordinary profit (loss)
Gain on sale of non-current assets
Insurance claim income
Compensation income
Subsidy income
Extraordinary income
Loss on retirement of non-current assets
Loss on disaster
Loss on store closings
Provision for loss on store closings
Extraordinary losses
Profit (loss) before income taxes
Income taxes - current
Income taxes - deferred
Income taxes
Profit (loss)
Profit (loss) attributable to owners of parent